First Nebraska Trust Co Acquires New Position in Cardinal Health, Inc. $CAH

First Nebraska Trust Co bought a new position in shares of Cardinal Health, Inc. (NYSE:CAH) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 81,879 shares of the company’s stock, valued at approximately $18,218,000. Cardinal Health accounts for 1.5% of First Nebraska Trust Co’s portfolio, making the stock its 16th largest holding.

A number of other large investors also recently made changes to their positions in CAH. Downshift Financial LLC grew its stake in shares of Cardinal Health by 3,666.7% during the third quarter. Downshift Financial LLC now owns 113 shares of the company’s stock worth $25,000 after purchasing an additional 110 shares during the period. Maryland Capital Advisors Inc. increased its holdings in Cardinal Health by 12,600.0% in the third quarter. Maryland Capital Advisors Inc. now owns 127 shares of the company’s stock valued at $28,000 after purchasing an additional 126 shares during the last quarter. Investors Research Corp acquired a new position in Cardinal Health in the second quarter valued at about $29,000. Allied Private Wealth LLC acquired a new position in Cardinal Health in the second quarter valued at about $30,000. Finally, Brown Lisle Cummings Inc. lifted its stake in Cardinal Health by 1,562.5% in the third quarter. Brown Lisle Cummings Inc. now owns 133 shares of the company’s stock valued at $30,000 after buying an additional 125 shares during the period. Institutional investors and hedge funds own 87.17% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on CAH. Wells Fargo & Company boosted their target price on Cardinal Health from $245.00 to $277.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 12th. Mizuho increased their price target on shares of Cardinal Health from $250.00 to $280.00 and gave the company an “outperform” rating in a research report on Tuesday, October 20th. UBS Group lifted their price objective on shares of Cardinal Health from $280.00 to $295.00 and gave the stock a “buy” rating in a research note on Friday, October 16th. Robert W. Baird lifted their price objective on shares of Cardinal Health from $251.00 to $274.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 12th. Finally, Weiss Ratings upgraded shares of Cardinal Health from a “buy (b)” rating to a “buy (b+)” rating in a report on Thursday, October 8th. Sixteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus price target of $270.69.

Cardinal Health Trading Down 0.4%

CAH stock opened at $253.32 on Wednesday. The business’s 50-day moving average price is $238.67 and its two-hundred day moving average price is $222.72. The firm has a market cap of $58.66 billion, a PE ratio of 35.04, a P/E/G ratio of 1.53 and a beta of 0.53. Cardinal Health, Inc. has a 1-year low of $180.45 and a 1-year high of $259.84.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.42 by $0.49. The company had revenue of $63.67 billion during the quarter, compared to the consensus estimate of $65.15 billion. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%. The company’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the prior year, the company earned $2.08 earnings per share. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, analysts forecast that Cardinal Health, Inc. will post 12.55 earnings per share for the current year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, October 15th. Investors of record on Thursday, October 1st were given a $0.5158 dividend. The ex-dividend date was Thursday, October 1st. This represents a $2.06 annualized dividend and a dividend yield of 0.8%. Cardinal Health’s payout ratio is currently 28.49%.

Insider Activity

In other Cardinal Health news, insider Jessica Mayer sold 29,436 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $236.19, for a total value of $6,952,488.84. Following the transaction, the insider owned 33,076 shares of the company’s stock, valued at approximately $7,812,220.44. The trade was a 47.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Jason Hollar sold 44,529 shares of the company’s stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $236.18, for a total transaction of $10,516,859.22. Following the completion of the transaction, the chief executive officer owned 190,603 shares of the company’s stock, valued at $45,016,616.54. This trade represents a 18.94% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 210,271 shares of company stock worth $49,626,657. Corporate insiders own 0.12% of the company’s stock.

Cardinal Health Profile

Cardinal Health, Inc is a healthcare services and products company that supports the distribution and delivery of pharmaceuticals, medical products and related services. The company serves hospitals, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, as well as consumer health products, to pharmacies and healthcare institutions.